Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections.
about
Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection.Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinaseThe intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.Occult hepatitis B virus infection in liver transplant patients in a Brazilian referral centerHBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study.Ubiquitin-independent proteasomal degradation during oncogenic viral infections.Cryptic Hepatitis B and E in Patients With Acute Hepatitis of Unknown Etiology.Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell LymphomaHepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion.Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Hepatitis B virus inhibits apoptosis of hepatoma cells by sponging the MicroRNA 15a/16 cluster.The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis.Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review.Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation.HBxAg suppresses apoptosis of human placental trophoblastic cell lines via activation of the PI3K/Akt pathway.Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients.Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma.Quantification of intrahepatic total HBV DNA in liver biopsies of HBV-infected patients by a modified version of COBAS® Ampliprep/COBAS®TaqMan HBV test v2.0.PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.Indefinite antiviral therapy may be required after surgical resection for hepatocellular carcinoma complicating chronic hepatitis B.Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.Occult hepatitis B virus infection: a complex entity with relevant clinical implicationsAn overview of occult hepatitis B virus infection.Occult hepatitis B infection in a hemodialysis population in Guilan province, northern Iran.Occult hepatitis B virus infection in Japanese chronic hemodialysis patients.Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair.Occult HBV infection in HIV infected adults and evaluation of pooled NAT for HBV.Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection.Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
P2860
Q33717096-4BF46FAC-0D32-475E-A54C-EC81B2CF3F92Q33802988-FE2BD436-AA27-434D-98C6-36832EEC1340Q34206628-4009CD3B-336F-4D9F-A1D5-E953A6996218Q34502631-3F3EFF5A-9C21-42CD-BBB6-0E573F3FB88AQ34591251-BF108FCE-F81B-4D5D-B5EF-E3047FBE2331Q35354212-5EB55B91-AAE4-49E3-B6CA-E55D2DBF6822Q35686350-94FC8C71-C1DF-427F-97B8-7FA92A42B5DEQ36522482-2913902C-0FEC-4631-8EBE-7B1EB64D33C1Q36607449-56CDF6AC-43E0-4CE5-8148-C63D2DCB9075Q37295260-5CAA1B71-40CB-401A-9EC6-36DA4DD1768EQ37336779-AC5CF348-BC7B-47C1-8E43-29E33ED79598Q37365328-C2FDC2E1-CAE2-4F44-9849-EB4D7AA2E30CQ37800793-3303C9FA-6897-42A5-AB76-B4269958A214Q37891167-97A42D2D-1C6B-44A8-ACFC-DC4FCF99E7DEQ38125450-86C17007-13C5-4F51-8D3C-5D3A33048FF3Q38179533-B37808F6-2164-48E5-A3E7-431FAACFFFE8Q38388443-67996370-D7E2-46D6-8667-534884FA4050Q38474433-E7102BAB-00D9-42CB-AD79-E2DD7A7ED673Q38782761-7F3AA79E-54DD-4D1B-9069-4C902694126AQ39384102-1048A38E-506E-4958-85BE-DA4FD45DCD9DQ40240411-52009C9A-F5F0-416D-9683-DF64671E5D81Q40246617-1B0C9EB2-3740-4692-88D7-4C8B637E7468Q40606238-F1D74AB3-6020-4BA8-903F-AC02C1A0A506Q41879337-ECAECD35-3111-4DC1-9709-2281DB43833EQ41925761-221A8230-3B2A-4F27-A805-239414B8EB47Q42709679-A5497577-A9A1-42F1-A404-9226CB20696CQ42722415-C70AB466-27ED-40A9-977E-E97E91C85664Q43410808-13610D85-BB28-4E1A-95E2-33AF8554ED23Q45350919-949FA8F3-41B3-4C73-9818-7DF355661D01Q45365306-B88B8840-69E4-4327-8DD2-397BC88D576CQ47556463-43B68D1B-50A0-4BE4-93D7-7E07B1E757CBQ49612948-8D61EEB2-75F0-4965-8960-55A53C2014E6Q54356234-438C3E79-DF8C-4BB6-9216-70D8EBA2AB83
P2860
Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B virus-related hepa ...... of clear or occult infections.
@en
Hepatitis B virus-related hepa ...... of clear or occult infections.
@nl
type
label
Hepatitis B virus-related hepa ...... of clear or occult infections.
@en
Hepatitis B virus-related hepa ...... of clear or occult infections.
@nl
prefLabel
Hepatitis B virus-related hepa ...... of clear or occult infections.
@en
Hepatitis B virus-related hepa ...... of clear or occult infections.
@nl
P2093
P1476
Hepatitis B virus-related hepa ...... of clear or occult infections.
@en
P2093
Maria Stella De Mitri
Mauro Bernardi
Romina Cassini
P304
P356
10.1016/J.EJCA.2010.03.034
P577
2010-04-21T00:00:00Z